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 The precise pathobiology of precursor lesions, which de-
velop into pancreatic adenocarcinoma, remains controver-
sial. Recently, we encountered a patient with dysplastic le-
sion of the pancreas; a case in which a precursor lesion of 
the pancreatic carcinoma may have been documented. The 
patient was a 73-year-old female with epigastric discomfort. 
As part of a general check-up, she underwent abdominal ul-
trasound, which revealed the pancreatic duct in the pancre-
atic body to be slightly indented. Computed tomography (CT) 
scan revealed mild dilatation of the main pancreatic duct and 
a small low-density area (less than 1 cm in diameter). Endo-
scopic retrograde cholangiopancreatography (ERCP) showed 
the irregularity in the body of the main pancreatic duct. 
Under general anesthesia, resection of the distal portion of 
the pancreas was performed with splenic conservation. Path-
ological examination revealed focal hyperplastic epithelium 
of the pancreatic duct with moderate dysplasia. Expression 
of the proliferating cell nuclear antigen (PCNA) in the le-
sion was observed, indicating a slightly proliferative na-
ture. Mutant p53 protein was slightly expressed in the le-
sion. As is seen in this case, ductal hyperplasia of the 
pancreas might represent precursor lesions, and constitute 
part of a continuous development spectrum evolving into 
ductal adenocarcinoma of the pancreas with accumulation 
of genetic alterations.
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Introduction
 Although the precise pathobiology of precursor le-
sions that develop into pancreatic adenocarcinoma re-
mains controversial, elucidation of the mechanisms of 
tumorigenesis might possibly provide for earlier detec-
tion, prevention, and treatment. Thus far, infiltrating 
adenocarcinoma of the pancreas has been characterized 
at the molecular level, though little is currently known 
about the early events in the development of this neo-
plasm or about the role of precursor lesions in tumor 
development"). The identification of the precursor le-
sions to infiltrating adenocarcinoma of the panreas is 
especially important because most infiltrating cancers 
of the pancreas already have spread beyond the pan-
creas by the time the lesions are detected clinically. 
Recently, we encountered a patient with pancreatic 
hyperplasia for whom partial resection of the pancreas 
was performed. Here we describe the case and discuss 
an hypothesis regarding tumorigenesis.
Case report
 The patient was a 73-year-old female with epigastric 
discomfort, who was referred to our hospital in 1998 
due to hyperglycemia. As a part of general check up, 
she underwent abdominal ultrasound, which revealed 
the pancreatic duct in the pancreatic body, having an 
appearance similar to a string of beads. No particular 
family history existed. She had no history of alcohol 
abuse nor was she a heavy smoker. On admission, the 
patient's physical examination revealed no particular 
abnormal findings. In addition, count of blood ball cells, 
biochemistry (Amylase 105 IU/1), and tumor markers 
(CA19-9 27U/ml, Span-I 50U/ml) except for Dupan-2 
(190 U/ml) all showed normal data. Both her pancre-
atic exocrine (PFD test: 43.5%) and endocrine (75g oral 
glucose tolerance test was diabetes mellitus pattern)
function were poor. CT scan revealed mild dilatation 
of the main pancreatic duct and a small low-density 
area (less than 1 cm in diameter; Fig. 1). Preoperative 
ERCP showed the irregularity in the body of the main 
pancreatic duct (Fig. 2). Magnetic resonance imaging
showed slight dilatation of the main pancreatic duct 
and a small mass lesion in the body. Angiography re-
vealed no abnormalities. Due to a preoperative diagno-
sis of possible pancreatic cancer, under general anes-
thesia, resection of the distal portion of the pancreas 
was performed with splenic conservation. Pathological 
examination revealed focal hyperplastic epithelium of 
the pancreatic duct with dysplasia (Fig. 3 A, B, C). In
Fig 1. CT scan revealed mild dilatation of the main pancre-
      atic duct and a small low-density area less than 1 cm 
      in diameter (arrow).
Fig 2. Preoperative ERCP showed the irregularity in the 
      body of the main pancreatic duct.
Fig 3. Pathological examination revealed focal hyperplastic 
      epithelium of the pancreatic duct with some degree of 
      dysplasia. (A:100x, B:200x, C:400x)
addition, pyloric gland hyperplasia in the lesion was 
seen and slight inflammation was present in the whole 
resected specimen. The final histological diagnosis was 
ductal hyperplasia with moderate dysplasia of the 
pancereas. Expression for proliferating nuclear antigen 
(PCNA) was observed in the nucleus of the lesion 
(Fig. 4). Immunohistochemically, mutant p53 protein 
was expressed in the lesion. Also, both CA 19-9 and 
Carcinoembryonic antigen (CEA) protein were slightly 
expressed in the lesion. Post operative course was un-
eventful and the patient was discharged home. There 
has been no evidence of recurrence of the disease and 
she has been symptom-free for 1 year at this writing.
Fig 4. Slight expression of the proliferating nuclear antigen 
      (PCNA) was observed in the lesion. (200x)
Discussion
 In the present case, we may have detected a precur-
sor lesion of pancreatic carcinoma, which can be hardly 
detected clinically. In the resected specimen, slight ex-
pression of PCNA was observed in the lesion, indicating 
a slightly proliferative nature. Generally, aside from de 
novo development, it has been presumed that the de-
velopment spectrum of hyperplasia - dysplasia - carci-
noma in situ exists, although it is relatively difficult to 
prove in vivo 3, 4). Thus far, several reports have been 
published stressing the involvement of ductal hyper-
plasia in infiltrating adenocarcinoma of the pancreas, 
although the papillary hyperplasia - atypical hyperplasia 
(dysplasia) - to papillary adenocarnoma sequence has 
been relatively well investigated with regard to mucin 
producing adenocarcinoma 5, 5). Thus, although a puta-
tive development spectrum evolving into ductal adeno-
carcinoma of the pancreas was advocated, hyper or 
dysplastic lesions of -the pancreas are barely detected, 
though this may have been accomplished in the present
case. 
 Mutant p53 protein was slightly expressed in the le-
sion. In a previous report, it was shown that mutant 
p53 protein was expressed at 0% in normal duct, 55% 
in hyperplastic lesions, 67% in dysplastic lesions and 
80% in adenocarcinomas'). It has also been reported 
that K-ras mutation was highly related to carcinogenesis 
of pancreatic cancer, although it was not investigated 
in our case"). This finding implies a putative develop-
ment spectrum evolving into ductal adenocarcinoma of 
the pancreas with accumulation of genetic alteration. 
Ductal hyperplasia and dysplasia of the pancreas might 
represent precursor lesions, in a fashion similar to that 
seen in colorectal tumorigenesis with accumulating 
progressive genetic alterations such as p53 and K-ras'. 
 From a different perspective, it is presumed that 
pancreatic hyperplasia might be a different entity from 
hyperplasia of other organs such as gastrointestinal 
tract. Brat et al. stressed that the term "pancreatic 
hyperplasia" should be replaced by the more specific 
term "pancreatic intraepithelial neoplasia" since pancre-
atic hyperplasia can develop into infiltrating adenocar-
cinoma just as adenoma in the colorectum 10'. In their 
cases, adenocarcinoma developed long-term after detec-
tion of the atypical papillary hyperplasia. The differ-
ence of meaning of "hyperplasia" should be elucidated, 
in time, by further investigation with more detailed 
genetic clarification. 
 As seen in our case, chronic inflammation and/or 
ductal epithelial papillary hyperplasia may play a role 
in the pathogenesis of the tumor. However, thus far, 
the relationship between chronic pancreatitis and ductal 
neoplasma of the pancreas is still under discussion 11.12) 
In any event, the identification of the precursor lesions 
to infiltrating adenocarcinoma of the pancreas is espe-
cially important because most infiltrating cancers of 
the pancreas already have spread beyond the pancreas 
by the time the lesions are detected clinically. Our pa-
tient may have been fortunate since the lesion was 
resected prior to the development of infiltrating 
adenocarcinoma, which usually provides a poor prog-
nosis. 
 In summary, we experienced a case with hyperplasia 
of the pancreas with a somewhat dysplastic (morpho-
logincal and genetic) ' lesion. This type of lesion is 
rarely detected, and this case may thereby provide in-
formation regarding carcinogenesis of infiltrating 
adenocarcinoma of the pancreas, the development of 
which likely includes this step.
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